For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying ... providing a background level of blood glucose control ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions ... produces in Denmark or the U.S. Novo Nordisk produces its weight loss ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Jefferies analyst Lucy Codrington maintained a Sell rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK415.00. The company’s shares closed yesterday at DKK467.13.

Novo Nordisk A/S Bagsværd, Denmark, 3 April 2025 – Novo Nordisk today announced the following changes in Executive Management. After a distinguished career of 28 years with Novo Nordisk, hereof ...

Novo Nordisk today presented the full results from ... was consistent with that seen in previous semaglutide trials, and no new safety signals were observed. The incidence of serious adverse ...

Europe’s largest pharmaceutical firm, Novo Nordisk, saw its stocks tumble 27% in March, marking their worst monthly performance since July 2002. As of market close on 31 March, the Danish firm ...

LONDON/COPENHAGEN (Reuters) - Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday.

LONDON, March 17 (Reuters) - Danish company Novo Nordisk's (NOVOb.CO), opens new tab membership in a UK pharmaceutical industry body has been restored after a two-year suspension for breaching a ...

Novo Nordisk (NVO) presented results from STRIDE ... respectively; however, no SAEs leading to death were treatment-related. Discover the latest stocks recommended by top Wall Street analysts ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British Pharmaceutical Industry (ABPI) has reinstated the Danish drugmaker after seeing ...